Leaders in Cancer Screening and Precision Medicine
Leaders in exosome based diagnostics and precision medicine
Exosomics Siena is engaged in developing a new generation of non invasive assays for cancer screening and diagnostics. Our proprietary technology and liquid biopsy approach is suitable for all diagnostic steps in cancer detection and patients' management, including precision medicine and companion diagnostics.
We run and encourage collaborative projects with academic and industrial partners as part of our translational strategy. We also offer a number of services to both academic and industrial partners who can benefit from our exclusive approach and unique expertize in exosome science and liquid biopsy.